Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis

• Published in: Endoscopy (ISSN: 1438-8812), vol. 43, num. 1-13
• Publication date: 2011

Background and study aims: Low dose photodynamic therapy (LDPDT) may modify the mucosal immune response and may thus provide a therapy for Crohn's disease. We evaluated the efficacy and safety of this technique in a murine T cell-mediated colitis model.

Keywords: Inflammatory-Bowel-Disease ; Dependent Experimental Colitis ; Adjuvant-Enhanced Arthritis ; Delta-Aminolevulinic-Acid ; Crohns-Disease ; Barretts-Esophagus ; Light Dosimetry ; Scid Mice ; Apoptosis ; Lymphocytes

Reference

• EPFL-ARTICLE-166265
• doi:10.1055/s-0030-1256382
• View record in Web of Science

Record created on 2011-06-01, modified on 2017-05-12